NFKB1 and depressive symptom measurement: To summarise, the present study further supports that LPS-activated inflammasomes accelerate neuroinflammation and lead to depression by triggering PPARγ/CX3CR1/Nrf2 and the NF-κB/NLRP3 signaling pathways.